Clinical Trial

Imagery Rescripting as Treatment for Depression

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 6, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this multiple baseline case series study is to test Imagery Rescripting in depression. The main question\[s\] it aims to answer are: * does Imagery Rescripting lead to a reduction of depression and of believability of negative beliefs held by the participants? * does Imagery Rescripting also leads to reductions in worrying and brooding? * Participants will wait for 6-10 weeks (to assess time effects without treatment), followed by 5 weekly preparation sessions, 8-12 weekly Imagery Rescripting sessions, and 5 weeks post-treatment. * Participants will rate the believability of 3-5 core dysfunctional beliefs related to their depression as well as 2 items assessing depression severity on a weekly basis. In addition, they will fill out more extensive questionnaires on depression, worry and brooding before each phase, as well as at 5 weeks post-treatment, and 6 and 12 months follow-up.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-07-27; most recent amendment 2026-04-29.
Status change: Recruiting → Active, Not Recruiting 2026-04-29
Status change: Not Yet Recruiting → Recruiting 2023-08-10
Trial Details
NCT Number NCT05976945
Lead Sponsor University of Amsterdam
Collaborators: Academic Center for Trauma and Personality
Conditions Major Depressive Disorder, Persistent Depressive Disorder
Enrollment 10 participants
Start Date 2023-08-10
Primary Completion 2026-08-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-06